# Aspirin and Thienopyridine Resistance in Peripheral Arterial Disease

> **NCT03174990** · — · COMPLETED · sponsor: **University of California, Davis** · enrollment: 195 (actual)

## Conditions studied

- Peripheral Arterial Disease
- Clopidogrel, Poor Metabolism of

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03174990
- **Lead sponsor:** University of California, Davis
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08-31
- **Primary completion:** 2013-05-17
- **Final completion:** 2013-12-20
- **Target enrollment:** 195 (ACTUAL)
- **Last updated:** 2017-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03174990

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03174990, "Aspirin and Thienopyridine Resistance in Peripheral Arterial Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03174990. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*